Cargando…
Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT
PTEN, a tumor suppressor, is found loss of function in many cancers, including colorectal cancer. To identify the synthetic lethal compounds working with PTEN deficiency, we performed a synthetic lethality drug screening with PTEN-isogenic colorectal cancer cells. From the screening, we found that P...
Autores principales: | Liu, Yifan, Yang, Eun Ju, Shi, Changxiang, Mou, Pui Kei, Zhang, Baoyuan, Wu, Changjie, Lyu, Junfang, Shim, Joong Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211175/ https://www.ncbi.nlm.nih.gov/pubmed/32398948 http://dx.doi.org/10.7150/ijbs.42197 |
Ejemplares similares
-
Synthetic lethality of RB1 and aurora A is driven by stathmin-mediated disruption of microtubule dynamics
por: Lyu, Junfang, et al.
Publicado: (2020) -
Inhibition of histone acetyltransferase (HAT) activity by HBZ extends beyond the p300/CBP HAT family
por: Wright, Diana G, et al.
Publicado: (2014) -
Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
por: Wu, Changjie, et al.
Publicado: (2018) -
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022) -
HBZ inhibits the HAT activity of the cellular coactivators p300 and CBP
por: Wright, Diana, et al.
Publicado: (2011)